Collaborating to improve treatment for chronic lymphocytic leukemia and B-cell lymphomas
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
This study is looking for ways to improve treatment and care for people with chronic lymphocytic leukemia (CLL) and B-cell lymphomas, and it offers patients a chance to join exciting new clinical trials that could help them respond better to therapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11031397 on NIH RePORTER |
What this research studies
This research focuses on enhancing patient care and survival for individuals with chronic lymphocytic leukemia (CLL) and B-cell lymphomas, which are among the most common adult blood cancers. The approach involves developing and managing a portfolio of clinical trials, including those sponsored by the National Cancer Institute (NCI). Patients may have the opportunity to participate in innovative trials aimed at overcoming resistance to therapy and improving treatment outcomes. The research is led by Dr. Deborah Stephens at the Huntsman Cancer Institute, who is dedicated to advancing the standard of care for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults diagnosed with chronic lymphocytic leukemia or B-cell lymphomas, particularly those who have not responded well to existing therapies.
Not a fit: Patients with other types of cancers or those who are not diagnosed with chronic lymphocytic leukemia or B-cell lymphomas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better survival rates for patients with chronic lymphocytic leukemia and B-cell lymphomas.
How similar studies have performed: Previous research has shown success in improving treatment outcomes for similar blood cancers through collaborative clinical trials, indicating a promising approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Stephens, Deborah — Univ of North Carolina Chapel Hill
- Study coordinator: Stephens, Deborah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.